Advertisement
 
YOU ARE HERE: LAT HomeCollectionsAdvanced Corneal Systems Inc
IN THE NEWS

Advanced Corneal Systems Inc

MORE STORIES ABOUT:
FEATURED ARTICLES
BUSINESS
December 1, 1998 | BARBARA MARSH, Barbara Marsh covers health care for The Times. She can be reached at (714) 966-7762 and at barbara.marsh@latimes.com
Advanced Corneal Systems Inc., which develops experimental treatments for eye disorders, is anticipating its first sales. The Irvine company said the Mexican National Ministry of Health has approved the sale of its top drug, Vitrase, as a treatment for eye hemorrhage. Company studies show that the drug clears blood that floods the watery gel inside the eye as a complication of diabetes and other diseases, a condition that can lead to permanent blindness.
ARTICLES BY DATE
BUSINESS
December 9, 1998 | Barbara Marsh, Barbara Marsh covers health care for The Times. She can be reached at (714) 966-7762 and at barbara.marsh@latimes.com
Advanced Corneal Systems Inc. is one step closer to marketing its experimental drug for clearing hemorrhages from the eye. The Irvine developer of experimental therapies for visual disorders says it has initiated final-stage tests in the United States of its drug "Vitrase." The company plans to enroll 800 patients in the study, which is designed to prove the drug's safety and effectiveness for treating optical hemorrhages that often result from diabetes.
Advertisement
BUSINESS
December 9, 1998 | Barbara Marsh, Barbara Marsh covers health care for The Times. She can be reached at (714) 966-7762 and at barbara.marsh@latimes.com
Advanced Corneal Systems Inc. is one step closer to marketing its experimental drug for clearing hemorrhages from the eye. The Irvine developer of experimental therapies for visual disorders says it has initiated final-stage tests in the United States of its drug "Vitrase." The company plans to enroll 800 patients in the study, which is designed to prove the drug's safety and effectiveness for treating optical hemorrhages that often result from diabetes.
BUSINESS
December 1, 1998 | BARBARA MARSH, Barbara Marsh covers health care for The Times. She can be reached at (714) 966-7762 and at barbara.marsh@latimes.com
Advanced Corneal Systems Inc., which develops experimental treatments for eye disorders, is anticipating its first sales. The Irvine company said the Mexican National Ministry of Health has approved the sale of its top drug, Vitrase, as a treatment for eye hemorrhage. Company studies show that the drug clears blood that floods the watery gel inside the eye as a complication of diabetes and other diseases, a condition that can lead to permanent blindness.
BUSINESS
July 12, 1998
* Don M. Bailey, president and chief executive of Comarco Inc., has been named to the additional position of chairman. He succeeds Gerald D. Griffin, who will remain a director. Bailey has been president of Comarco since 1990, and president and chief executive since 1991. Griffin, who joined the board of directors in 1986, became chairman in 1988. Yorba Linda-based Comarco provides wireless-communications products and services. * Robert B.
BUSINESS
December 8, 1997
* L.J. Edgcomb has been named president of the Orange County division of John Laing Homes in Irvine. He succeeds Larry Webb, who continues as California division president. Edgcomb joined the company earlier this year as senior vice president of operations. Before that, he was Orange County division manager at Warmington Homes. * Arthur B. Branstine has been appointed vice president, fluid handling products for Furon Co., a Laguna Niguel manufacturer of engineered polymer components.
BUSINESS
November 12, 1997 | MARLA DICKERSON, TIMES STAFF WRITER
Hollywood films and high tech have the sizzle. The defense industry still packs plenty of political clout. But when it comes to attracting venture capital in Southern California, the eyes have it. And the brain catheters. And artificial pancreases.
Los Angeles Times Articles
|